Jacob van Naarden, Chief Business Officer at Loxo Oncology, Inc. (LOXO), sold 5,200 shares at $168.85 ($869K) on 2018-10-03, disclosed to the SEC on 2018-10-05.
Open-market sale of $869k LOXO by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $165.13 | 2,000 | $330K | 38.0% |
| 2 | $165.89 | 400 | $66K | 7.6% |
| 3 | $167.19 | 500 | $84K | 9.6% |
| 4 | $168.85 | 2,300 | $388K | 44.7% |
| Total | $167.03 avg | 5,200 | $869K | 100% |
| Filing → |
| LOXO | SELL | 2018-12-12 | $426K | — | Filing → |
| LOXO | SELL | 2018-12-12 | $120K | — | Filing → |
| LOXO | SELL | 2018-11-28 | $1.5M | — | Filing → |